Investigating these mechanisms, potentially through approaches involving perforin inhibitors or Fas-deficient models, would provide critical insights into the molecular processes by which Tregs mediate the reduction of CD8+ T cells in diabetes-resistant NOD.Stat5b-CA mice. The gene discussed is CD8A; the disease is diabetes mellitus.